Successful management of low-stage neuroblastoma without adjuvant therapies: A comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2504-2510

  Evans, A E ^a   Silber, J H ^a   Shpilsky, A ^a   D'Angio, G J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0029739031     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2504     Document Type: Article

References (23)

1. Breslow N, McCann B: Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098-2103, 1971
2. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastoma tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-413, 1984
3. Silber JH, Evans AE, Fridman M: Models to predict outcome from childhood neuroblastoma: The role of serum ferritin and tumor histology. Cancer Res 51:1426-1433, 1991
4. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
5. Kaplan EI, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
6. Lee ET: Statistical Methods for Survival Analysis. Belmont, CA, Wadsworth, 1980, pp 122-145
7. Hayes FA, Green A, Hustu O, et al: Surgicopathological staging of neuroblastomas: Prognostic significance of regional lymph node metastases. J Pediatr 102:59-62, 1983
8. Ninane J. Pritchard J, Morris-Jones PM, et al: Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. Arch Dis Child 57:438-442, 1982
9. Rosen EM, Cassady JR, Kretschmar C, et al: Influence of localregional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12:260-263, 1984
10. Nitschke R, Smith EI, Shochat S, et al: Localized neuroblastoma treated by surgery: A Pediatric Oncology Group study. J Clin Oncol 6:1271-1279, 1988
11. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
12. Nitschke R, Smith EI, Altshuler G, et al: Postoperative treatment of nonmetastatic visible residual neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:1181-1188, 1991
13. De Bernardi B, Rogers D, Carli M, et al: Localized neuroblastoma. Surgical and pathological staging. Cancer 60:1066-1072, 1987
14. Kushner BH, Cheung N-KV, La Quaglia MP, et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996
15. Hsu LL, Evans AE, D'Angio GJ: Hepatomegaly in neuroblastoma stage 4s: Criteria for treatment of the vulnerable neonate. Med Pediatr Oncol (in press)
16. Sacks H, Chalmers TC, Smith H Jr: Randomized versus historical controls for clinical trials. J Am Med 72:233-240, 1982
17. Berthold F, Trechow R, Utsch S, et al: Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 14:207-215, 1992
18. Shuster JJ, McWilliams NB, Castleberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study. Am J Clin Oncol 15:295-303, 1992
19. Zeltzer PM, Marangos PJ, Evans AE, et al: Serum neuronspecific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 57:1230-1234, 1986
20. Brodeur GM, Seeger RC, Schwab M. et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
21. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the Nmyc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
22. Look AT, Hayes FA, Nitschke R, et al: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231-235, 1984
23. Look AT, Hayes FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc amplification in childhood neuroblastoma. A Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991